Diversity of post-translational modifications and their identification using mass spectrometry
Structural changes in proteins can occur from various events including genomic mutations, alternative splicing, proteolytic cleavage, chemical and enzymatic modifications in amino acid side chains. These changes occurring inside cells and tissues cannot be recognized in genomic level, other than by proteomic analysis which makes it possible to identify these alternations. Since these modifications are highly diverse, many proteomic approaches are required to identify them. This review will describe the diverse characteristics of PTMs in proteins and the analytical approaches including mass spectrometry employed to identify them.
Cellular protein modifications
Modifications in the side chain of amino acids of proteins can alter the protein's charge, polarity and spatial features, and induce conformational changes which in turn cause changes in a variety of protein characteristics. These modifications can occur reversibly or irreversibly, and be mediated by enzymes or non-enzymatic way. In addition, many changes at the genomic level such as point mutation, deletion and insertion, alternative splicing etc. induce alterations in amino acid sequences. Identification of these changes may require different analytical MS methodologies, depending on the type of the modification.
Amino acid substitution
Amino acid substitution, which can occur by point mutation in the genome, or chemical conversion of one amino acid to another, is involved in 346 of the listed 900 modifications in the database of protein modifications for mass spectrometry, UniMod (www.unimod.org). The Human Gene Mutation Database (www.hgmd.org), as of August 2011, lists more than 113,000 mutations of 4,122 human genes, which include missense/nonsense mutation, splicing, small and gross deletion/insertion, complex rearrangement and repeat variation. Although a single amino acid substitution usually does not seem affect a protein's structure in most cases, several proteins are known in which a change in single amino acid change caused significant changes in the protein structure and stability. An example is a single mutation in hemoglobin causes sickle cell anemia, one of several monogenic diseases. 
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Another way to occur amino acid substitution is by chemical conversion of one amino acid to another, for example, Asn and Gln can be converted to Asp and Glu by deamination. Cys residues are converted to Ser during oxidative stress (Jeong et al., 2011) . Mass spectrometry has been extremely useful in identifying unexpected amino acid substitutions and deletion and insertion of amino acids (Fig. 1) . However, finding unknown substitutions with routine peptide sequencing in conjunction with tandem MS is not to easy, because MS/MS spectra searching algorithm matches only known sequences. In order to find these unexpected amino acid changes, in MS/MS spectra, it is necessary to carry out de novo partial sequencing of a peptide from an MS/MS spectrum. To find unknown amino acid changes, we suggest using the searching algorithm MOD i combined with peptide sequencing using tandem MS.
Alternative splicing
Insertion and deletion of large amino acid sequences can markedly affect the protein structure, in contrast to changes in single amino acid residues which mostly do not. Alternative splicing can occur in a number of ways including exon skipping, exon insertion, alternative 5' initiation, 3' termination and even intron inclusions. About 74% of multi-exon genes produce alternatively spliced protein variants in humans. These PTMs result in proteins differing in binding affinity, enzymatic activity, localization within the cell, and stability. Alternative splicing therefore, is a common phenomenon in biology. Existence of the alternatively spliced variants can be detected only at the protein level. However, it is not easy to find spliced variants without separating each variant population. 2D-PAGE is an useful tool to separate the different variants because of their differences in their charges (isoelectric points) and molecular weights (Fig. 1) . Separation of each population of protein variants is a prerequisite for employing mass spectrometry to identify the sequence changes. By comparing the chromatogram of each population, it is possible to find peptide products generated from alternative splicing, and then de novo sequencing the differential peptides.
Proteolytic cleavage
Proteolytic cleavage is obviously an irreversible protein modification. Proteins can be cleaved by various proteolytic enzymes, which are classified into serine proteases, cysteine proteases, aspartic acid proteases and metalloprotease, depending on their active sites of action. Employing genome sequence analysis, 553 proteases were identified in the human genome: 203 Ser proteases, 143 Cys proteases, 21 Asp proteases and 186 metalloproteases. Since the substrate specificity of each protease is not known in many cases, the proteolytic products can be further identified only at protein level. Unexpected cleavage products are not easy to detect without mass spectrometry (Fig. 1) . Full peptide sequencing with tandem MS is the only way to characterize the cleaved products using the same strategy employed to detect the alternative splicing variants.
Enzymatic modifications
Cellular protein modifications are designed by nature to initiate and regulate essential cellular processes. The mechanisms for PTM regulation are not fully understood because of their complexity. More than 200 kinds of enzymes (>5% of total proteins) have been shown to be involved in catalyzing the various chemical modifications of protein side chains. In the human genome, it has been shown that more than 500 proteases, more than 500 protein kinases, more than 150 protein phosphatases, 5 class methyltransferases, a series of acetyltransferase and deacetylase, oxidoreductases, E1, E2, E3 for ubiquitination, sumoylation and neddylation, operate among others. Since most enzyme induced protein modifications are reversible, they are readily removed during the biological processes after they function as signalling molecules. Enzymatic modification of amino acid side chains occurs in various ways depending on the species of amino acids, as shown in Table 1 . For example, phosphorylation at -OH in Ser, Thr and Tyr residues, can be promoted by various protein kinases and one third of total human proteome is estimated to comprise substrates of various proteins kinases, predicted to number more than 500. Phosphorylated proteins serve as substrates of kinases. They are readily dephosphorylated by phosphatases. Tyrosine kinase receptors (e.g. PDGF receptor, VEGF receptor) are auto-phosphorylated by ligand binding and transduce the signalling as turn 'on' switch, and later dephosphorylated by phosphatases, as turn 'off' switch. These reversible modifications act as on/off switches in various signalling pathways by controlling phosphorylation and dephosphorylation. Thus it becomes important to identify, which residues are phosphorylated, which kinase acts on them, how long signalling is turned on and which phosphatases are involved in the turn off. In addition to kinases and phosphatases which signal phosphorylation/dephosphorylation, other enzyme pairs are involved in reversible modifications; e.g. acetyltransferase and deacetylase, acyltransferase and deacylase, methyltransferase and demethylase, ubiquitinating and deubiquitinating enzymes, chemical oxidation and peroxidase and reductase, glycosylase and deglycosylase, among others. Irreversible modifications are also possible, for example, crosslinkiing of the proteins by transglutaminase. Although many modifications have been identified thus far, an enormous number of unknown protein modifications are waiting to be discovered. Mass spectrometry offers an useful analytical approach to identifying and quantifying the unknown novel modifications, modification sites, and the accompanying structural changes. The relevant methodologies are detailed in section 2.2. Table 1 . These proteomic studies for PTM analysis can be divided into two groups. One group consists of large scale analysis of one kind PTM after enriching the modified proteins and identifying PTMs, necessitated by low abundance of modified proteins. The second group comprises comprehensive analyses of multiple modifications in one protein because the diversity of modifications in the chosen protein (Fig. 2) .
Non-enzymatic chemical modifications
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Large scale analysis of same type of PTMs in many proteins
Large scale identification of PTMs is not easy problem to be solved because each modification has its distinct and unique chemical property including chemical affinity, solubility, charge and hydrophobicity. In order to identify one kind of PTM in many proteins with high throughput analysis, the enrichment of modified proteins or peptides was combined with peptide sequencing with tandem MS. Affinity-based enrichment of post-translationally modified proteins and peptides can provide to increase the relative abundance of a selected PTM in the sample. Several studies have reported the systemic identification of same PTM to understand wide signaling cascade (Table 2) . Phosphorylation, the most extensively studied PTM, has been reported in more than 10,000 proteins, variously concerned with specific signaling, in cell cycle, cancer, receptor function, and stress responses (Olsen et al., 2010; Dephoure et al., 2008; Rikova et al., 2007; Kim et al., 2002 , Kim et al., 2007a and 2007b . Intriguingly, although phosphorylation seems to play a pivotal role in various signal cascades, phosphorylated peptides constitute minor fraction of the total protein mileau. Due to the low abundance of phosphopeptides and low degrees of phosphorylation, enrichment phosphopeptides is essential prior to MS analysis ( Fig. 2A ). There are several strategies for enrichment of phosphoproteins, including immobilized metal ion affinity chromatography (IMAC), titanium dioxide (TiO 2 ) chromatography, and immunoaffinity chromatography with anti-pY antibodies (Thingholm et al., 2009 
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proteins with or without treatment, were separated on 2D-PAGE and phosphorylated proteins on Tyr residues were detected by anti-pY antibody, and each spot was analyzed with tandem MS (Kim et al., 2007a and 2007b) . Separation of modified protein from abundant unmodified proteins on 2D-PAGE is an informative way to obtain only modified proteins. However, attempts to enrich other PTMs have met with limited success. Acetylation of Lys residue is another abundant PTM with fundamentally important regulatory function. Acetylation occurs as a co-translational and post-translational modification of proteins, such as histones, p53 and tubulins. The acetyl group can become attached to either the -amino group at the protein N-terminus or the ε-amino groups of Lys residues and eliminate the positive charge of the amino group to make it uncharged. Thus, Lys acetylation, a reversible PTM, regulates protein interaction with negatively charged DNA, thereby playing a key regulatory role in gene expression. For example, acetylation of histone or p53 inhibits the DNA binding and renders DNA more relaxed, and deacetylation reverses this process. However, enrichment methods, except for immunoaffinity purification, have not been developed thus far. There remains a need for robust methods that can address the complexity and dynamic range of the cellular proteome. In contrast to phosphorylation and acetylation as small chemical modifications, ubiquitination, a PTM involving the covalent attachment of ubiquitin, a 76-residue polypeptide, to Lys residue, induce bulk change of protein. Depending on the nature and site of linkage, ubiquitination regulates protein degradation, signal transduction, intracellular localization and DNA repair. Ubiquitination is readily detected by peptide sequencing with tandem MS, because Gly-Gly adduct of ubiquitin C-terminal (+114 Da increase) can easily be detected at Lys ubiquitinated residues in tryptic peptides. Most common enrichment methodology for ubiquinated proteins is immunoaffinity purification employing exogenously tagged ubiquitin (Danielsen et al., 2011) . Recent studies have employed endogenous ubiquitin enrichment using ubiquitin binding motifs such as ubiquitin interacting motif (UIM) or ubiquitin associated (UBA) domain, rather than Ubantibody (Manzano et al., 2008) . About 200 ubiquitinated proteins binding to UBA domain of p62 were identified in Arabidopsis. Glycosylated proteins exist as heterogenous populations characterized by a range of molecular weight, and play important role in membrane surface localization and as receptors by raising the hydrophilicity and changing the surface charge. The O-linked -Nacetylglucosamine (O-GlcNAcylation) also plays a vital role modifying Ser and Thr residues in many cellular processes, including signal transduction, protein degradation, and regulation of gene expression. Since the lectin, Wheat Germ Agglutinin (WGA), has affinity for terminal N-acetylglucosamine (GlcNAc) and sialic acid residues, lectin immobilized affinity chromatography has been recently used for enrichment O-GlcNAc modified peptides (Vosseller et al., 2006) . Biotinylated O-GlcNac peptides are captured by avidin chromatography (Wang et al., 2010) . Oxidative modification has emerged as a major PTM involved in oxidative stress. 4-Hydroxy-2-nonenal (HNE), generated during lipid peroxidation, modifies proteins. 4-HNE adducts are commonly enriched by immunoaffinity chromatography or solid-phase hydrazide enrichment strategy (Mendez et al., 2010; Roe et al., 2007) . Other oxidation adducts of reactive Cys residues play key roles in cellular regulations. Recently dimedone, and chemicals that specifically label sulfenic acid, have been used to enrich sulfenic acid using biotin tagged dimedone, and to identify ROS sensitive Cys residues (Giron et al., 2011 , Seo YH et al., 2009 , Leonard et al., 2009 . Large scale proteomic identifications of proteins containing the same kind of PTM, e.g., phosphorylation or acetylation, can be interesting if the relationship between a specific modification and biological function can be established. For example, phosphorylated, acetylated, glycosylated and oxidized proteins move in acidic direction, ubiqutinated and sumoylated proteins move upward by increasing molecular weight and disulfide bonded proteins move either upward with intermolecular disulfide or downward with intramolecular disulfide bond. This information can allow the prediction of the type of PTM and overcomes the limitations due to the complexity of PTMs. Following the separation of the heterogeneous populations of modified proteins on 2D-PAGE, we try to obtain comprehensive PTM information via replicate nanoLC-ESI MS/MS analysis by raising the modified peptide coverage (Seo et al., 2008) . To facilitate the characterization of PTMs as much as possible, we devised the strategy of selective exclusion acquisition in replicate run analysis. In data dependent acquisition (DDA) mode, most intense precursor ions are redundantly acquired in nanoLC-ESI MS/MS run. If the exclusion list is not used, identification of low-intensity ions in the presence of high-intensity ions would be far less successful in randomly repeated runs. The number of obtainable MS/MS spectra is limited in a single run analysis, because we select MS/MS spectra having appropriate quality and quantity by optimizing the experimental procedure including sensitivity, scan time, number of ion channel, time for return to MS scan from MS/MS scan, elution time in LC etc. This is the reason for selectively excluding unwanted high-intensity MS/MS data generation. Exclusion methodology is a way to separate wanted peptides from unwanted ones. The overall scheme of Selectively Excluded Mass Screening Analysis (SEMSA) is shown in Fig. 3 . An exclusive implementation using this unmodified peptide library, resulted in efficient identification of low abundant PTMs (Fig. 4) . As the SEMSA progressed, exclusion list is cumulated and then separation of unwanted peptide can ameliorate the quality of MS/MS spectra. The LC-MS procedure is repeated three times to obtain more MS/MS data. The MS data of the first run are then processed by ProteinLynx v2.1 for peak deconvolution and peak list generation. The resulting MS/MS spectra are then generated and submitted to Mascot and ProteinLynx database searches to obtain peptide identifications. Only unmodified peptides now serve as candidates for a precursor exclusion list, in terms of m/z and LC run times in the subsequent run. After the peak list of the second separation is generated, the peaks are matched to peptides previously identified and included in the exclusion list are automatically blocked from the peak selection prior to MS/MS acquisition. The ranges of tolerance windows of excluding peak are typically determined by mass accuracy and resolution in the MS scan and peak widths in the chromatogram. This PTM specific exclusion strategy enables less intense PTM peptides to be identified, thereby enhancing confidence level of PTM identifications. To determine whether the GAPDH spots on 2D-PAGE have differential modifications, we exhaustively examined the PTMs in each population using SEMSA (Seo et al., 2008) . Diverse PTM populations were identified in various peptides (Fig. 5) . Especially, multiple modifications of Cys residue in the peptide containing active site ( 152 CTTNC 156 ) were clearly demonstrated: intra-disulfide between 152C and 156C, oxidation to cysteic acid (152C), and transformation of Cys to Ser (152C). Simultaneously, 247C was shown to transform to sulfinic acid, mainly dehydroalanine and cysteic acid. This indicates that reactive Cys residues in GAPDH can be oxidized to various oxidation states depending upon tertiary structural environments. Results of these studies clearly established the exact oxidation sites, oxidation species, and the levels of oxidation states. This strategy was applied for finding many low abundant modifications including phosphorylation, acetylation, glutathionylation and some novel modifications (Hwang et al., 2009; Lee et al., 2010; Jeong et al., 2011) . 
Fig. 2. Schematic diagram to identify one type modification in cellular proteins (A) and comprehensive modifications in one protein (B).

Comprehensive identification of multiple PTMs in the same protein by MS
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Combination of 2D-PAGE for separating modified populations and MS/MS analysis using SEMSA, makes it possible to identify low abundant modified peptides and to raise the identified peptide coverage nearly over 90%.
Bioinformatic tools for identifying multiple and novel modifications
T h e t y p e s a n d s i t e s o f P T M s i n a p r o t e i n v a r y w i d e l y . A l t h o u g h M S a l l o w s r a p i d identification of many types of PTMs, data analysis and interpretation of MS/MS spectra for identification of PTMs remain a major challenge. Most of the available search tools accept only a few types of PTMs as input. We have developed interpretative tools called MOD i (Na et al., 2008) and DBond (Choi et al., 2010) for rapidly interpreting tandem mass spectra of peptides with all known types of PTMs simultaneously without limiting a multitude of modified sites. Early approaches to PTM identification using MS/MS involved exhaustive searches of all possible combinations of PTMs for each peptide from a protein database (Eng et al., 1994; Perkins et al., 1999) . Because the search space grows exponentially as the number of PTMs increases, these early approaches performed a restrictive search that took into account only a few types of PTMs during data analysis, ignoring all others. Investigators were obliged to guess the PTMs expected to exist in a sample prior to a search, and many potentially important PTMs may have been overlooked. A few tools were recently introduced for blind PTM search. MS-Alignment (Tsur et al., 2005) predicts PTMs expected in a sample by spectral alignment between a database peptide and a spectrum followed by InsPecT search . ModifiComb (Savitski et al., 2006) introduced a ΔM histogram between unassigned spectra and base peptides found in a database. These blind approaches predict PTMs based on the frequency of mass shifts (indicating potential PTMs) in a sample. Thus, they all have the intrinsic weakness of missing rare or infrequently observed PTMs that might provide important clues to understanding the function of a protein. Although many approaches have been developed to take into account several types of PTMs, most of them assume that there will be a single variable PTM per peptide and ignore peptides with multiple modifications. MOD i (pronounced "mod eye") is essentially a sequence tag approach (Mann et al., 1994; Tabb et al., 2003) (Fig. 6 ). It constructs a partial sequence of a peptide from an MS/MS spectrum using de novo sequencing. MOD i differs from previous approaches in that it simultaneously uses multiple sequence tags derived from a spectrum by introducing a notion of a tag chain, a combination structure of multiple sequence tags. A tag chain offers an effective localization of modified regions within a spectrum and thus allows rapid identification of multiple PTMs in a peptide, obviating search space explosion by inspecting PTMs only in the modified regions of a peptide. The tag chain algorithm resists de novo sequencing errors, whereas most tag-based approaches depend critically on good de novo interpretations. This approach is scalable and performs well even when more than 900 types of modification are considered and the number of potential PTMs in a peptide increases. Compared with established tools, MOD i reliably identifies a greater variety of modification types in multiply modified peptides and even detects modifications of low abundance.
Another new algorithm called "DBond" analyzes disulfide linked peptides based on specific features of disulfide bonds (Choi et al., 2010) . Identifying the sites of disulfide bonds in a protein is essential for thorough understanding of a protein's tertiary and quaternary structures and its biological functions. Disulfide linked peptides are usually identified indirectly by labeling free sulfhydryl groups with alkylating agents, followed by chemical reduction and mass spectral comparison or by detecting the expected masses of disulfide linked peptides on mass scan level. However, these approaches for determination of disulfide bonds become ambiguous when the protein is highly bridged and modified. For accurate identification of disulfide linked peptides, we developed an algorithmic solution for the analysis of MS/MS spectra of disulfide bonded peptides under non-reducing condition. To determine disulfide linked sites, DBond takes into account fragmentation patterns of disulfide linked peptides in nucleoside diphosphate kinase (NDPK) as a model protein, considering fragment ions including cysteine, cysteine thioaldehyde (-2 Da), cysteine persulfide (+32 Da) and dehydroalanine . Using this algorithm, we successfully identified about a dozen novel disulfide bonds in a hexa EF-hand calcium binding protein secretagogin and in methionine sulfoxide reductase. We believe that DBond, which takes into account disulfide bond fragmentation characteristics and posttranslational modifications, offers a novel approach for automatic identification of unknown disulfide bonds as well as their sites in proteins from MS/MS spectra (Choi et al., 2010) .
Examples of multiply modified proteins
Employing SEMSA, a sensitive mass spectrometric method for detecting low abundant protein modifications, and MOD i and DBond algorithm for searching for unknown modifications of separated protein on 2D-PAGE, we characterized the nature as well as the relative abundances of these hitherto unknown Cys modifications in cellular GAPDH purified on 2D-PAGE (Jeong et al., 2011) . We found unexpected mass shifts at active site Cys 
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residue (ΔM = -16, -34 and +64 Da) in addition to those of previously known oxidation products including sulfinic and sulfonic acids, and disulfide bonds. Similar changes were also found in other ROS-sensitive proteins including NDPK A, PRX6 and mitochondrial proteins. Mass differences of -16, -34 and +64 Da are presumed to reflect the conversion of Cys to Ser, DHA and Cys-SO 2 -SH respectively. The plausible pathways leading to their formation from Cys were deduced from the distribution of the disulfide bonds and were confirmed in model systems by analyzing three dimensional protein structures and by employing model chemical reactions. Also sulfenic and sulfinic acids were detected as acrylamide adducts (ΔM = +87 and +103 Da) in samples on SDS-PAGE. These findings suggest that diverse modifications of redox-active Cys can be generated by ROS. These findings of unknown modifications are due to the sensitive mass spectrometric method, SEMSA, and unrestricted PTM search tool, MOD i and DBond. These strategies should lead to identification of many unknown modifications which doubtless occur in various signaling pathways and in health and disease. Combining 2D-PAGE for separating heterogenous population of one protein, SEMSA for analyzing low abundant modified peptide with MS/MS and MOD i for searching algorithm to identify novel and multiple modifications, makes it possible to identify multiple and low abundant modifications of protein comprehensively.
Conclusion
Many protein modifications including amino acid substitutions, alternative splicing and post-translational modifications regulate the various biological functions of proteins by altering the protein-protein interactions, protein localization and protein activity. Understanding the relationship between protein modifications and their physiological activities will help define the principles on biological regulation. To demonstrate the exact protein function and its regulation, comprehensive identifications of low abundant and unexpected modification is essential. For the comprehensive identification of PTMs, peptide sequencing using tandem MS can give the most effective results. However, identification of PTMs does not simple as protein identification using MS. The enrichment of low abundant PTMs is necessary. Because most enrichment approaches of many type of PTMs are insufficient, we suggest the use of a combination of approaches: first separating the heterogeneous populations of a protein with multiple modifications on 2D-PAGE, then comprehensively identifying the PTMs employing SEMSA of MS/MS for detecting low abundant modifications and raising peptide coverage up to 100%, and searching MS/MS spectra using searching algorithm MOD i for multiple and unexpected modifications. With these combined powerful proteomic tools, it will be possible to discover hitherto unknown PTMs in proteins, that influence various signaling pathways. This will hold the key for fully understanding the roles of proteins in biological and pathological processes in molecular level. 
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